doxepin has been researched along with Bladder Diseases in 1 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Doxepin was given at bedtime in a single 50 mg." | 2.66 | Doxepin in the treatment of female detrusor overactivity: a randomized double-blind crossover study. ( Jørgensen, L; Lose, G; Thunedborg, P, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lose, G | 1 |
| Jørgensen, L | 1 |
| Thunedborg, P | 1 |
1 trial available for doxepin and Bladder Diseases
| Article | Year |
|---|---|
Doxepin in the treatment of female detrusor overactivity: a randomized double-blind crossover study.
Topics: Adult; Aged; Circadian Rhythm; Double-Blind Method; Doxepin; Female; Humans; Middle Aged; Muscle Con | 1989 |